|
MAML1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.163300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.400900E-04 |
| Normal-vs-Stage2 |
4.873400E-01 |
| Normal-vs-Stage3 |
9.403400E-01 |
| Normal-vs-Stage4 |
9.377600E-01 |
| Stage1-vs-Stage2 |
1.933650E-01 |
| Stage1-vs-Stage3 |
1.977950E-02 |
| Stage1-vs-Stage4 |
3.346000E-01 |
| Stage2-vs-Stage3 |
5.563200E-01 |
| Stage2-vs-Stage4 |
6.579000E-01 |
| Stage3-vs-Stage4 |
9.190000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.823600E-03 |
| Normal-vs-AfricanAmerican |
3.175500E-02 |
| Normal-vs-Asian |
9.107400E-01 |
| Caucasian-vs-AfricanAmerican |
8.542600E-01 |
| Caucasian-vs-Asian |
4.840000E-01 |
| AfricanAmerican-vs-Asian |
4.763400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.777900E-04 |
| Normal-vs-Female |
7.584800E-01 |
| Male-vs-Female |
2.707600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.946400E-02 |
| Normal-vs-Extreme_Weight |
4.620400E-03 |
| Normal-vs-Obese |
1.397550E-01 |
| Normal-vs-Extreme_Obese |
3.315100E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.332200E-01 |
| Normal_Weight-vs-Obese |
3.688000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.857000E-01 |
| Extreme_Weight-vs-Obese |
2.363800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.784000E-01 |
| Obese-vs-Extreme_Obese |
2.118600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.799400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.399400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.76349999999803E-05 |
| Normal-vs-Age(81-100Yrs) |
7.568600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.836400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.218400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.089700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.996800E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.904400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.105600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.922200E-03 |
| Normal-VS-Type2 PRCC |
5.803200E-03 |
| Normal-VS-KIRP CIMP |
6.256400E-01 |
| Normal-VS-Unclassified PRCC |
7.396600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.164000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.137400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.322180E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.202000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.043020E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.390800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.035700E-04 |
| Normal-vs-N1 |
4.253400E-01 |
| Normal-vs-N2 |
6.174000E-01 |
| N0-vs-N1 |
1.621780E-02 |
| N0-vs-N2 |
1.022200E-01 |
| N1-vs-N2 |
9.111400E-01 |
|
|
